Based on previous results on the stability of ischemia under aflibercept treatment, this improvement in DR score and the decrease in predominantly peripheral lesion number seen on color retinography suggest that monitoring DR by color retinography is insufficient in patients treated with anti-VEGF. This evidence concerns the gene VEGFA and ischemia.